357 filings
Page 8 of 18
SC 13G/A
TRIL
Trillium Therapeutics Inc.
13 Feb 20
Beneficial ownership report (amended)
2:25pm
6-K
TRIL
Trillium Therapeutics Inc.
7 Feb 20
Trillium Therapeutics Announces Changes to
7:00am
SC 13D/A
TRIL
Trillium Therapeutics Inc.
4 Feb 20
Beneficial ownership report (amended)
5:19pm
SC 13G
TRIL
Trillium Therapeutics Inc.
3 Feb 20
Beneficial ownership report
4:31pm
SC 13G
TRIL
Trillium Therapeutics Inc.
3 Feb 20
Beneficial ownership report
4:03pm
6-K
TRIL
Trillium Therapeutics Inc.
29 Jan 20
Trillium Closes US$117 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
7:48am
SUPPL
TRIL
Trillium Therapeutics Inc.
23 Jan 20
Supplemental materials (foreign)
4:36pm
6-K
TRIL
Trillium Therapeutics Inc.
23 Jan 20
Current Report
4:28pm
6-K
TRIL
Trillium Therapeutics Inc.
23 Jan 20
Trillium Announces Pricing of US$101,700,000 Public Offering of Common Shares and Series Ii Non-voting Convertible First Preferred Shares
9:01am
SUPPL
TRIL
Trillium Therapeutics Inc.
23 Jan 20
Supplemental materials (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
22 Jan 20
Trillium Announces Proposed Public Offering of Common Shares and Series Ii Non-voting Convertible First Preferred Shares
4:02pm
SC 13G
Venrock Healthcare Capital Partners III, L.P.
21 Jan 20
Trillium Therapeutics Inc.
4:52pm
SC 13G/A
TRIL
Trillium Therapeutics Inc.
21 Jan 20
Trillium Therapeutics Inc.
11:27am
6-K
TRIL
Trillium Therapeutics Inc.
16 Jan 20
Current report (foreign)
8:01am
6-K
TRIL
Trillium Therapeutics Inc.
7 Jan 20
Trillium Therapeutics Provides Update on Its TTI-621 and TTI-622 CD47 Programs
8:29am
SC 13G
TRIL
Trillium Therapeutics Inc.
31 Dec 19
Trillium Therapeutics Inc.
4:24pm
6-K
TRIL
Trillium Therapeutics Inc.
14 Nov 19
Interim Condensed Consolidated Financial Statements
7:14am
S-8
TRIL
Trillium Therapeutics Inc.
14 Nov 19
Registration of securities for employees
7:10am
6-K
TRIL
Trillium Therapeutics Inc.
6 Nov 19
Trillium Therapeutics to Report Preclinical Data on Its Sting Program at the Sitc 34TH Annual Meeting
7:15am
6-K
TRIL
Trillium Therapeutics Inc.
22 Oct 19
Trillium Therapeutics Announces Corporate Restructuring and Provides CD47 Program Update
9:00am